(505) 254-7784 pchelp@pcsanm.org

About Us
Contact Us
Donate

Home
Start Here
- Beginner’s Guide
- Next Steps
Meetings
Resources
Education & Info
Fall Conference
Newsletters
Early Detection
- Early Detection
- Free PSA Test

Select Page

FDA Approves FoundationOne Liquid CDx as Companion Diagnostic for Olaparib Treatment for Metastatic CRPC

by admin_63069 | Feb 4, 2021 | Related Topics

See page 2 of Us TOO International’s Hot SHEET

What’s New

Non-Invasive Treatment for Prostate Cancer Prevents Side-Effects Related to Surgery
State of the Science Report
Same-Day Robotic Urologic Surgery During the COVID-19 Crisis Not Riskier
Study Supports Shorter Radiation Regimen in High-Risk Prostate Cancer
Geography Seen as a Factor in Overtreatment of Low-Risk Prostate Cancer

Disclaimers:

PCSANM provides education, information, and support, not medical advice. Please contact your physician for all your medical concerns. No copyrighted material belonging to others is knowingly used without permission. If any is inadvertently used without permission, please contact our office. Articles are selected from a variety of sources to give as wide a range of content as possible. PCSANM does not endorse or approve, and assumes no responsibility for, the content, accuracy, or completeness of the information presented.

2533 Virginia St. NE, Suite C Albuquerque, NM 87110

Phone: (505) 254-7784
Toll Free: (800) 278-7678
Fax: (505) 254-7786

Email: pchelp@pcsanm.org